Discovery opens door for breast, prostate cancer treatments

April 22, 2013, University of Western Australia
The WAIMR researchers involved in the publication. [Back Row]: Dr Shane Colley, Prof Peter Leedman, Michael Epis, Dr Keith Giles. [Front Row]: Dianne Beveridge, A/Prof Andrew Redfern, Lisa Stuart.

(Medical Xpress)—A team of Western Australian cancer researchers interested in the strong link between hormones and cancer have discovered three new molecules that may have an important role to play in future breast and prostate cancer treatments.

The paper, which has just been published in the leading international journal the Proceedings of the National Academy for Sciences (PNAS), is the result of many years of laboratory work by scientists at the Western Australian Institute for Medical Research (WAIMR) and it is hoped that the discovery will translate to better outcomes for breast and prostate cancer patients in the clinic.

First author on the paper, Perth oncologist Associate Professor Andrew Redfern said that about 200 West Australian cancer patients died each year because of a failure to control oestrogen in female or testosterone in male prostate cancer patients.

"Currently, drugs used to treat these cancers are successful at first, but advanced cancer returns in a proportion of patients," Associate Professor Redfern said.

"Our current treatments are only really targeting part of the signalling pathway related to oestrogen and in 70 percent of cases the tumours are finding a way to sneak around the oestrogen receptor block currently being used. In prostate cancer, the testosterone receptor blocking treatments are also failing and 95% of prostate cancers are testosterone driven. This medical research is looking for new approaches."

Endocrinologist Professor Peter Leedman who leads WAIMR's Laboratory for Hormone Dependent cancers said the team had discovered these molecules while on a "targeted fishing expedition" examining tissue samples from a library, and using a molecule discovered by Texan collaborator Bert O'Malley from Baylor College of Medicine, as "bait."

"These newly identified molecules are key regulators in the oestrogen receptor and the testosterone receptor signalling pathways. In addition to regulating hormone action in these cancers, three of these molecules are part of a complex that processes tiny RNAs inside cells, called microRNAs. In so doing they can regulate a third of all human genes. That's what makes it so interesting, as it would appear that these molecules are great at multi-tasking and can do it from different parts of the cell".

"These molecules are all activating hormone action in these cancer cells, and there is some evidence that too much of one of these molecules in is not good news for cancer patients," he said.

"We hope our paper, which provides big insight into how these molecules work at the bench, will translate towards the bedside and eventually be able to help improve outcomes."

Dr Redfern is using the findings of the PNAS paper in a follow up clinical study to explore the importance of each of the in tissue samples from 500 breast at Royal Perth Hospital.

Explore further: CRT unveils 'screen test' for potential drugs to treat oestrogen positive breast cancer

More information: The paper is entitled "RNA-induced silencing complex (RISC) Proteins PACT, TRBP and Dicer are SRA binding nuclear receptor coregulators."

Related Stories

CRT unveils 'screen test' for potential drugs to treat oestrogen positive breast cancer

March 6, 2012
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.

Lessening the impact of cancer-causing hormones

February 9, 2012
Increasing the production of proteins that help rid the body of toxins may play a crucial role in the fight against breast and prostate cancer, researchers from Flinders University believe.

Researchers confirm breast cancer regulator also found in prostate cancer

June 1, 2012
Researchers at Clarkson University in Potsdam, N.Y., led by Chemistry & Biomolecular Science Professor Costel C. Darie, in collaboration with researchers from Columbia University, have now found the binding partner of TDF, ...

Scientists find new drug target in breast cancer

May 22, 2011
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.